Ask Warren

iNtRON Biotechnology

048530 · KOSDAQ · ₩048530 · 인트론바이오

₩2,790▼ ₩85 (2.96%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩2B₩1.9B₩1.7B₩1.6B₩1.2B₩1.2B₩1.5B₩1.2B
Cost of sales₩1.1B₩997M₩816M₩717M₩566M₩536M₩703M₩608M
Gross profit₩932M₩886M₩888M₩907M₩659M₩650M₩819M₩601M
Operating income−₩1.6B−₩2.2B−₩2B−₩2.1B−₩2B−₩1.8B−₩1.3B−₩1.6B
Net income−₩2.3B−₩2.3B−₩4.2B−₩1.5B−₩1.1B−₩2.1B−₩1.3B−₩1.3B
Net income to shareholders−₩2.3B−₩2.3B−₩4.2B−₩1.5B−₩1.1B−₩2.1B−₩1.3B−₩1.3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩68B₩71B₩74B₩79B₩81B₩82B₩86B₩91B
Current assets₩39B₩41B₩43B₩46B₩46B₩47B₩51B₩56B
Cash and equivalents₩26B₩25B₩26B₩28B₩30B₩31B₩33B₩39B
Total liabilities₩6.2B₩6.3B₩4.4B₩4.7B₩6B₩5.7B₩2.5B₩1.5B
Current liabilities₩4.1B₩4.2B₩4.1B₩4.4B₩5.7B₩5.4B₩1.3B₩1.1B
Borrowings₩4.8B₩4.8B₩3B₩3B₩4.7B₩861M₩861M₩1.5M
Total equity₩62B₩64B₩70B₩74B₩75B₩76B₩84B₩89B
Shareholders' equity₩62B₩64B₩70B₩74B₩75B₩76B₩84B₩89B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩581M−₩2.1B−₩1.6B−₩992M−₩4.6B₩1.9B−₩118M−₩788M
Free cash flow−₩581M−₩2.1B−₩1.6B−₩992M−₩4.6B₩1.9B−₩118M−₩788M
Dividends paid₩0₩0₩0₩0₩0₩3.2B₩0₩0

Consolidated where available. Amounts in won.

Also known as: iNtRON Biotechnology / 인트론바이오 / 048530 / KRX:048530

Source: KRX statistical information